Ignite Creation Date:
2024-05-05 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000230
Status:
COMPLETED
Last Update Posted:
2016-05-06
First Post:
1999-09-20
Brief Title:
Buprenorphine Detoxification With Two Types of Treatment BBD III - 12
Sponsor:
University of Vermont
Organization:
University of Vermont
Study Overview
Official Title:
Buprenorphine Detoxification With Two Types of Treatment BBD III
Status:
COMPLETED
Status Verified Date:
1996-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with naltrexone
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01-06969-12 | US NIH GrantContract | None | httpsreporternihgovquickSearchR01DA006969 |
| R01DA006969 | NIH | None | None |